GPCR - Company ID 0001888886
The table below shows Structure Therapeutics Inc.'s balance sheet line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash & equivalents | $799.62M | $169.51M | $129.79M |
| Short-term investments | $646.57M | $714.01M | $337.53M |
| Receivables | - | - | - |
| Inventory | - | - | - |
| Total current assets | $1.57B | $891.21M | $473.61M |
| Property, plant & equipment | $6.65M | $3.48M | $3.23M |
| Goodwill | - | - | - |
| Total assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.58B |
| $903.33M |
| $482.02M |
| Accounts payable | $13.86M | $8.02M | $4.74M |
| Total current liabilities | $63.28M | $36.02M | $24.74M |
| Long-term debt | - | - | - |
| Total liabilities | $67.54M | $38.49M | $29.05M |
| Retained earnings | -$470.30M | -$329.10M | -$206.57M |
| Total equity | $1.52B | $864.84M | $452.97M |